Back

Click Chemistry-Based Strategy for Modular Ligand Attachment to siRNAs: Toward Extrahepatic RNAi

Radler, J. A.; Filipiak, E.; Marquant, A.; Ojansivu, M.; Czapik, T.; Hill, A.; Ahlskog, N.; Roudi, S.; Barradas, C.; Huang, Y.; Saher, O.; Wood, M.; Zain, R.; Honcharenko, M.; EL Andaloussi, S.

2026-05-22 molecular biology
10.64898/2026.05.21.726808 bioRxiv
Show abstract

Efficient extrahepatic delivery of siRNAs remains a major limitation for broadening their therapeutic potential. Using a modular, orthogonal click chemistry platform, we generated 28 siRNA conjugates varying in ligand class, valency, and spatial arrangement. Following systemic administration, fatty acid conjugates - particularly palmitic acid (C16) - outperformed sterol- and phospholipid-based designs in promoting extrahepatic gene silencing, with preferential activity observed in heart and skeletal muscle. Increasing ligand valency through 3',5'-bis-conjugation generally enhanced activity compared to 5-mono conjugation. Nevertheless, bis-C22 conjugates showed increased hepatic activity, suggesting a shift in tissue distribution linked to hydrophobicity. Architectural parameters further modulated outcomes: Branched 5' C16 conjugates, bearing two lipids on one terminus, were markedly less active than their bis counterparts and required short PEG spacers to restore activity. Notably, bis-lipid conjugation strategies that enhanced extrahepatic activity for an siRNA did not translate to an ASO gapmer, underscoring modality-specific constraints. Together, these findings delineate structure-activity relationships and establish bis-fatty-acid conjugation as a robust design principle for achieving extrahepatic RNAi. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=78 SRC="FIGDIR/small/726808v1_ufig1.gif" ALT="Figure 1"> View larger version (23K): org.highwire.dtl.DTLVardef@287a47org.highwire.dtl.DTLVardef@17407eborg.highwire.dtl.DTLVardef@b40435org.highwire.dtl.DTLVardef@804352_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Journal of the American Chemical Society
199 papers in training set
Top 0.5%
12.0%
2
ACS Central Science
66 papers in training set
Top 0.1%
8.2%
3
ACS Chemical Biology
150 papers in training set
Top 0.1%
8.2%
4
Advanced Materials
53 papers in training set
Top 0.4%
6.6%
5
Journal of Medicinal Chemistry
68 papers in training set
Top 0.2%
6.1%
6
Nature Biotechnology
147 papers in training set
Top 2%
6.1%
7
Nature Communications
4913 papers in training set
Top 31%
6.1%
50% of probability mass above
8
Cell Chemical Biology
81 papers in training set
Top 0.5%
4.7%
9
Angewandte Chemie International Edition
81 papers in training set
Top 0.7%
4.7%
10
Angewandte Chemie
12 papers in training set
Top 0.1%
4.0%
11
Journal of Controlled Release
39 papers in training set
Top 0.5%
2.0%
12
Molecular Therapy Nucleic Acids
32 papers in training set
Top 0.3%
2.0%
13
Nucleic Acids Research
1128 papers in training set
Top 10%
1.8%
14
Nature Chemistry
34 papers in training set
Top 0.4%
1.8%
15
ChemMedChem
15 papers in training set
Top 0.3%
1.6%
16
Advanced Science
249 papers in training set
Top 12%
1.6%
17
Chemical Science
71 papers in training set
Top 1%
1.2%
18
Bioconjugate Chemistry
17 papers in training set
Top 0.2%
1.1%
19
Molecular Therapy
71 papers in training set
Top 2%
1.1%
20
Chemical Communications
24 papers in training set
Top 0.9%
0.9%
21
Nature Chemical Biology
104 papers in training set
Top 3%
0.9%
22
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 44%
0.8%
23
Small
70 papers in training set
Top 1%
0.8%
24
ACS Synthetic Biology
256 papers in training set
Top 3%
0.7%
25
Acta Pharmaceutica Sinica B
11 papers in training set
Top 1%
0.7%
26
eLife
5422 papers in training set
Top 60%
0.7%
27
Cell Reports Physical Science
18 papers in training set
Top 1%
0.6%